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1. Introduction 
There is a large body of evidence suggesting a role 
for CAMP in mediating smooth muscle relaxation 
[l-3]. Our own investigations with oestrogen pre- 
treated rat myometrium demonstrated that both the 
relaxing agent epinephrine and the contracting agent 
PGEl promote similar rises in CAMP levels with the 
expected saturation of intracellular CAMP receptor 
proteins [4-61. These observations were not consistent 
with the assumption of an exclusive role for the 
adenylate cyclase-CAMP system in mediating uterine 
relaxation. On the other hand, marked increases in 
cGMP levels have been obtained in various types of 
smooth muscles in response to certain stimulants that 
promote contraction [l-3]. Nevertheless in a number 
of cases, cellular cGMP content could not be systemati- 
cally related to the contractile activity of the muscle 
[7-91. The present investigation was designed to 
evaluate modulation of cGMP levels in rat myo- 
metrium in response to various contracting and 
relaxing agents. The effects of phosphodiesterase 
inhibitors and guanylate cyclase activators were also 
examined. The regulation of cGMP accumulation in 
the myometrium and its possible role in uterine 
contractility are discussed. 
Abbreviations: CAMP, adenosine 3’,5’Cyclic monophosphate; 
cGMP, guanosine 3’,5’cyclic monophosphate; MIX, 
3-isobutyl-l-methyl xanthine; EGTA, ethauedioxy-bis- 
(ethylamine) tetraacetic acid; PC, prostaglandins 
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2. Materials and methods 
2 .l . Chemicals 
CAMP, cGMP (PL Biochemical Inc.), theophylline, 
carbamylcholine hydrochloride (Merck Darmstadt), 
1 -methyl3-isobutyl xanthine (Aldrich), oxytocine, 
2’-Osuccinyl-cGMP (Sigma Chemical Co J. c [3H]AMP 
(CEA, France). 12SI-labelled succinyl-cGMP tyrosine 
methyl ester was prepared by P. Pradelles and F. Dray 
(URIA, Institut Pasteur, France). The antibody used 
for radioimmunoassay of cGMP was from Institut 
Pasteur Production, France. Prostaglandins E2 and Fzo 
were from Upjohn Co. 
2.2. Tissue preparation and incubation 
Uteri were obtained from oestrogen pretreated 
rats and myometrial strips were prepared free of 
endometrium. Tissue incubation and preparation 
of trichloracetic acid extracts were essentially as in 
[5]. The soluble TCA extracts were used for CAMP 
and cGMP estimations. 
2.3. Assay of cGMP and CAMP 
cGMP was measured according to the radio- 
immunoassay method developed [lo] after the 
succinylation step proposed [ 1 l] in order to increase 
the assay sensitivity. Free antigen was separated from 
the bound antigen-antibody complex by precipitation 
with cold ethanol (P. Pradelles and F. Dray, personal 
communication). In each assay series, the extent of 
succinylation was routinely controlled and averaged 
a value of 80-90%. In some experiments, prior to 
cGMP assay, extracts were purified on Dowex AG 1 -XI 
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formate columns [ 121 which adequately separate 
CAMP from cGMP. The purification step was not 
routinely conducted, since values obtained were 
similar to those determined without purification. 
CAMP was estimated as described [5] according 
to [13]. 
3. Results and discussion 
3 .l . Effect of phosphodiesterase inhibitors on CAMP 
and cGMP content of rat rnyometrium 
Basal levels of cGMP in rat myometrium equilibrated 
in Krebs Ringer at 37’C average 0.37 f 0.04 pmol/mg 
protein. These conditions yield a cAMP/cGMP ratio 
equal to 13-l 5. Two phosphodiesterase inhibitors, 
theophylline and 1 -methyl3+obutyl xanthine (MIX) 
evoked a significant rise in both cGMP and CAMP, in 
a dose-dependent manner (table 1). However in all 
cases, the increase in cGMP was more pronounced 
than that of CAMP. The value for cGMP may reach 
lo-fold that of the control while that of CAMP under 
the same conditions was increased by 2-fold. All the 
tested concentrations of MIX that promoted such 
increases in cGMP levels exerted also a relaxing effect 
on rat myometrium and antagonized contractions 
elicited by prostaglandins (E and F), oxytocin and 
carbamylcholine. 
3.2. Effect of carbamylcholine and other contracting 
agents 
It has been shown that cholinergic stimulation in a 
variety of tissues including different smooth muscle 
preparations, leads to cellular accumulation of cGMP 
[3,10,14-161. Carbamylcholine had a very slight 
stimulatory effect on cGMP accumulation in rat 
myometrium (0.44 + 0.05 and 0.53 f 0.05 pmol 
cGMP/mg protein with 50 PM and 100 JLM carbamyl- 
choline, respectively). It was however difficult to 
conclude to any consistent stimulatory effect since 
in the presence of either phosphodiesterase inhibitor, 
theophylline or MIX, cGMP levels were not modified 
by the addition of different concentrations of carbamy 
choline. The ability of the cholinergic agent to induce 
a rise in cGMP could not be improved by increasing its 
concentration up to 500 PM, whether tension was 
applied or not on uterine segments and whether cGMP 
was measured in the tissue alone or in the tissue plus 
incubation medium. Under such conditions, carbamyl- 
choline evoked myometrial contractions, and this effec 
was prevented by atropine. Hence the present findings 
confirm some previous observations [7 ,171 and suggest 
that the rat uterus appears to be an exception where 
stimulation of muscarinic receptors does not lead to 
consistent increases in tissue cGMP content. 
Moreover, a series of other contracting agents, 
Table 1 
Effect of phosphodiesterase inhibitors on cGMP and CAMP contents 
of rat myometrium 
cGMP CAMP cAMP/cGMP 
Addition (pmol/mg protein) 
- 0.37 f 0.05 5.0 f 1.2 13 
Theophylline 0.5 0.69 f 0.09 5.4 f 0.2 7.7 
(mM) 10 1.90 f 0.38 9.9 f 0.7 5.2 
MIX 55 1.25 f 0.15 7.40 ?r 0.3 5.9 
(MM) 138 1.79 f 0.36 9.01 + 0.27 5.0 
276 2.72 + 0.4 
500 3.9 f 0.66 
1000 4.1 * 0.55 
Incubation was carried out for 3 min in the absence or presence of theophylline or 
MIX at the indicated concentrations. Samples were extracted with TCA, CAMP and 
cGMP were separated by Dowex AC 1X8 formate column chromatography before 
each specific assay (see section 2). Values represent he means f standard errors of 
3-6 different experiments, each carried in duplicate 
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oxytocin, PGE?, PGF2(,, at a concentration range 
of l-l 00 a, as well as 100 mM K’ did not detectably 
affect cGMP content of the rat myometrium incubated 
either in the absence or in the presence of 55 PM MIX. 
Under these conditions, with the exception of PGEz 
which markedly increased CAMP content, none of the 
contracting agents had any affect on basal evels of 
CAMP [4,5]. Epinephrine in a concentration range of 
0.5-20 FM did not also exert any effect on myometrial 
cGMP content. Hence in either case where the muscle 
was promoted to contract by PGE2 or to relax by 
epinephrine [5] there was an increase in the CAMP/ 
cGMP ratio as compared to the control. 
3.3. Effect of guanylate cyche activators 
Hydroxylamine is a potent activator of guanylate 
cyclase [ 181 and produces cGMP accumulation i
slices of different tissues [89]. Results outlined in 
table 2 show that hydroxylamine and sodium nitro- 
prusside xerted a significant increase in cGMP level 
of rat myometrium. Both effects were dose dependent 
and potentiated in the presence of MIX. Under such 
conditions, no effect on basal CAMP levels could be 
demonstrated. 
Table 2 
Effect of hydroxylamme and sodium nitroprusside on 
cGMP levels of rat myometrium 
cGMP pmol/mg protein 
Addition (mM) - MIX MIX (55 PM) 
- 0.37 f 0.05 1.44 f 0.19 
Hydroxylamine 
0.1 
1 
5 
0.66 f 0.1 (4.21- 3.46) 
1.04 f 0.1 8.8 f 1.0 
1.42 * 0.24 (10.1 -12.0) 
Sodium nitroprusside 
0.1 
0.25 
0.50 
1.0 
0.52 f 0.05 
1.07 f 0.29 9.72 f 2.3 
1.93 f 0.28 
2.12 f 0.21 16.5 f 2.2 
Myometrial strips were incubated in the absence or presence 
of 55 MM MIX for 3 mm and incubation was further continued 
for 3 mm in the presence of hydroxylamine or sodium 
nitroprusside at the indicated concentrations. Values represent 
the means f standard errors of 8 different experiments 
except for the figures in parentheses which represent individual 
values of 2 separate xperiments 
3.4. Role of Cap 
The elevation of cGMP levels in smooth muscles in 
response to agents that stimulate contractions, in 
general has been described as a Ca”dependent process 
[15,16,19]. The data depicted in fig.1 indicate that 
the basal turnover of cGMP in rat myometrium was 
not effectively changed by incubation in a Ca”-free 
medium containing 4 mM EGTA. Moreover the 
increase in cGMP due to 55 PM MIX as well as the 
stimulation induced by hydroxylamine could still be 
observed in these Ca?‘deprived preparations. In fact, 
careful analysis of the results indicated that Ca’+seem! 
to exert a rather inhibitory effect. The same observa- 
tion could be made for sodium nitroprusside (not 
shown). 
Hence it is clear that in the rat myometrium, the 
Ca2+dependent mechanism, through which cGMP 
accumulation may occur, does not significantly operat 
under our experimental conditions. This may explain 
the lack of effect of carbamylcholine orhigh K’ in 
increasing intracellular cGMP concentrations as 
compared to the stimulatory activities of these 
agents in a series of investigated tissues [191. On the 
I cGMP pmoles/ng Protein 
2.4 mM Ca8+ 
MIX NtiflH MIX 
N”;OH 
Fig. 1. Role of Ca’+ on basal cGMP levels and on the stimulato: 
effect of MIX and NH,OH. Myometrial strips were incubated 
for 1 h in a normal (2.4 mM) Ca* medium or in a Ca’+-free 
medium containing 4 mM EGTA. Tissues were transferred to 
a fresh corresponding medium with or without 55 PM MIX 
and in the absence or presence of 1 mM NH,OH (see legend 
to table 2). Values represent means * standard errors of 
8 different experiments. 
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CAMP nor cGMP could be considered as exclusive 
regulators, both cyclic nucleotides may still exert a 
modulatory activity at the level of alternative 
mechanisms (e.g., regulation of cellular concentrations 
and transport of Ca23 operating in the control of 
uterine contractility. 
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Fig.2. Tracing of isometric contractions of isolated rat uterus 
in the presence of PGE,. Effect of hydroxylamine. The 
concentration of PGE, was 1.5 MM and NH,OH 2 mM. 
w = washing with buffer solution. 
other hand, significant guanylate cyclase activity 
appeared to be expressed in the myometrium through 
the alternate mechanism which does not require Ca2+ 
[8,9,19] but seems rather slightly inhibited by the 
divalent cation. 
3.5 . Effect of hydroxylamine on uterine contractility 
Contractile activity of isolated uterine strips was 
measured as in [ 51. When 2 mM NH20H was added 
to a uterine horn stimulated to contract by PGE2, 
relaxation was observed (fig.2). This relaxing effect 
was reversible, with two successive washings restoring 
a normal contractile response to PGE2. Hydroxylamine 
was also able to antagonize both oxytocin and PGFzo, 
evoked contractions. It is pertinent to point out that 
epinephrine induced relaxation of the myometrium 
is not accompanied by any change in tissue cGMP 
levels, but rather by an important elevation of intra- 
cellular CAMP. 
In conclusion, the results obtained in the foregoing 
experiments, adding to those in [4-71, are not consis- 
tent with a general theory involving a direct causal 
relationship between changes in CAMP or cGMP and 
uterine relaxation or contraction. While neither 
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